The beneficial effects of E2 on a variety of metabolic diseases, including NAFLD and insulin resistance, are largely attributed to its binding to classical nuclear estrogen receptors (ER) α and β (12), although rapid signaling mediated by E2 has also been acknowledged as essential for systemic estrogenic activities (13). Here, ESR1 is linked to metabolic dysfunction-associated steatotic liver disease.